↓ Skip to main content

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Overview of attention for article published in Alzheimer's Research & Therapy, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
8 tweeters
googleplus
1 Google+ user

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Published in
Alzheimer's Research & Therapy, December 2018
DOI 10.1186/s13195-018-0455-y
Pubmed ID
Authors

Gayatri Devi, Philip Scheltens

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 25%
Student > Ph. D. Student 15 20%
Student > Master 8 11%
Student > Bachelor 6 8%
Other 5 7%
Other 9 12%
Unknown 14 18%
Readers by discipline Count As %
Neuroscience 19 25%
Biochemistry, Genetics and Molecular Biology 11 14%
Medicine and Dentistry 6 8%
Agricultural and Biological Sciences 5 7%
Psychology 3 4%
Other 13 17%
Unknown 19 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2021.
All research outputs
#597,350
of 20,362,325 outputs
Outputs from Alzheimer's Research & Therapy
#63
of 1,058 outputs
Outputs of similar age
#19,215
of 413,725 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#2
of 120 outputs
Altmetric has tracked 20,362,325 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,058 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.